Job title: Senior Director, Process Development, Biologics CMC
Chiali is Senior Director of Process Development, Biologics CMC at Teva Pharmaceuticals, overseeing both upstream and downstream process development of biologic drug substance. She obtained Ph.D. degree in Chemical Engineering at MIT. She has 20 years’ experience in process development, scale-up, technology transfer, and commercial production of biologics, as well as in tech transfer and commercialization of advanced therapy, with tenures at Janssen, GSK, Human Genome Sciences, and Centocor.
Roundtable Discussion: Drug Substance Process Development for Biologics 3:00 pm
• Which continuous processing technology would you consider as the most value-added? Why? • What is your organization’s goal for adopting continuous processing? Single Step, leveraging useful technologies, or end-to-end approach? • What is your organization’s decision making process on which technology should be adopted? Which functions are involved? What are the factors considered (Cost,…Read more
day: Stream 2 - Day 1 PM